Invention Grant
- Patent Title: Formulations
-
Application No.: US17738873Application Date: 2022-05-06
-
Publication No.: US11691954B2Publication Date: 2023-07-04
- Inventor: Thomas Edlund , Jacob Westman
- Applicant: BETAGENON AB
- Applicant Address: SE Umeå
- Assignee: BETAGENON AB
- Current Assignee: BETAGENON AB
- Current Assignee Address: SE Umeå
- Agency: Morrison & Foerster LLP
- Priority: GB 15094 2019.10.18
- Main IPC: C07D285/08
- IPC: C07D285/08 ; A61K9/14

Abstract:
There is provided an alkali metal salt of 4-chloro-N-[2-[(4-chlorophenyl)methyl]-3-oxo-1,2,4-thiadiazol-5-yl]benzamide and formulations thereof. This salt finds particular utility in the treatment or prevention of a disorder or condition ameliorated by the activation of AMPK.
Public/Granted literature
- US20220267287A1 NEW FORMULATIONS Public/Granted day:2022-08-25
Information query